Regulatory Loophole Enables Unproven Autologous Cell Therapies to Thrive in Australia
Author:
Affiliation:
1. The University of Melbourne, Melbourne, Victoria, Australia.
2. The University of Melbourne, Walter and Eliza Hall Institute of Medical Research, and Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australia.
Publisher
Mary Ann Liebert Inc
Subject
Cell Biology,Developmental Biology,Hematology
Link
https://www.liebertpub.com/doi/pdf/10.1089/scd.2014.0332
Reference3 articles.
1. Regulation of cellular therapy in Australia
2. A question of ethics: Selling autologous stem cell therapies flaunts professional standards
3. Self‐regulation of autologous cell therapies
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Critical considerations for public engagement in stem cell-related research;Stem Cell Reports;2023-02
2. Navigating the cartographies of trust: how patients and carers establish the credibility of online treatment claims;Sociology of Health & Illness;2019-10
3. Ethical development of stem-cell-based interventions;Nature Medicine;2019-07
4. Public Engagement for Regulatory Reform: A Case Study of Autologous Stem Cell Therapy Regulation in Australia;Science Communication;2019-06-12
5. Stem cell/cellular interventions in human spinal cord injury: Is it time to move from guidelines to regulations and legislations? Literature review and Spinal Cord Society position statement;European Spine Journal;2019-05-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3